Japan’s Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other public-health threats.
Fujifilm’s U.S. unit, Fujifilm Diosynth Biotechnologies, may increase the stake to 100 percent after the initial purchase based on the achievement of certain milestones, it said in a statement. The purchase amount was not disclosed.
Fujifilm, once among the world’s biggest makers of photography film, has been expanding its bio pharmaceutical business, and in 2008 bought Toyama Chemical Co., whose influenza drug Avigan has been drafted to the fight against Ebola.
Help employers find you! Check out all the jobs and post your resume.
